Literature DB >> 7518664

Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.

Z N Tutuncu, A Bilgie, L G Kennedy, A Calin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7518664      PMCID： PMC1005361          DOI： 10.1136/ard.53.6.425-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation.

Authors:  N Nishimoto; K Yoshizaki; H Tagoh; M Monden; S Kishimoto; T Hirano; T Kishimoto
Journal:  Clin Immunol Immunopathol       Date:  1989-03

2.  Serum levels of interleukin-6 and acute phase responses.

Authors:  M W Nijsten; E R de Groot; H J ten Duis; H J Klasen; C E Hack; L A Aarden
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

3.  The natural history of ankylosing spondylitis. Does it burn out?

Authors:  L G Kennedy; L Edmunds; A Calin
Journal:  J Rheumatol       Date:  1993-04       Impact factor: 4.666

4.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

Authors:  F A Houssiau; J P Devogelaer; J Van Damme; C N de Deuxchaisnes; J Van Snick
Journal:  Arthritis Rheum       Date:  1988-06

5.  Correlation between rheumatoid factor and IL-6 activity in synovial fluids from patients with rheumatoid arthritis.

Authors:  T Sawada; S Hirohata; T Inoue; K Ito
Journal:  Clin Exp Rheumatol       Date:  1991 Jul-Aug       Impact factor: 4.473

6.  Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.

Authors:  V Gross; T Andus; I Caesar; M Roth; J Schölmerich
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

7.  The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

Authors:  A Waage; P Brandtzaeg; A Halstensen; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307
  7 in total
  15 in total

1.  The effect of IL-4 and MTHFR gene variants in ankylosing spondylitis.

Authors:  S Yigit; A Inanir; S Tural; B Filiz; A Tekcan
Journal:  Z Rheumatol       Date:  2015-02       Impact factor: 1.372

2.  Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.

Authors:  R J François; L Neure; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

3.  The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence.

Authors:  K J Ho; P Q Chen; C Y Chang; F J Lu
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

4.  Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis.

Authors:  A Bal; E Unlu; G Bahar; E Aydog; E Eksioglu; R Yorgancioglu
Journal:  Clin Rheumatol       Date:  2006-04-01       Impact factor: 2.980

5.  The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis.

Authors:  Ingo H Tarner; Ulf Müller-Ladner; Christine Uhlemann; Uwe Lange
Journal:  Clin Rheumatol       Date:  2008-12-17       Impact factor: 2.980

6.  The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Clin Rheumatol       Date:  2004-08-31       Impact factor: 2.980

7.  Soluble intercellular adhesion molecule 1 in spondylarthropathies.

Authors:  D Wendling; E Racadot; B Augé; E Toussirot
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

8.  Serum oxidative-antioxidative status in patients with ankylosing spondilitis.

Authors:  Mehmet Karakoc; Ozlem Altindag; Huseyin Keles; Neslihan Soran; Sahabettin Selek
Journal:  Rheumatol Int       Date:  2007-04-19       Impact factor: 2.631

9.  Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis.

Authors:  Ning-Sheng Lai; Jian-Liang Chou; Gary C W Chen; Su-Qin Liu; Ming-Chi Lu; Michael W Y Chan
Journal:  Mol Biol Rep       Date:  2014-02-16       Impact factor: 2.316

10.  Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.

Authors:  Fernando Kemta Lekpa; Cécile Poulain; Daniel Wendling; Martin Soubrier; Michel De Bandt; Jean Marie Berthelot; Philippe Gaudin; Eric Toussirot; Philippe Goupille; Thao Pham; Jérémie Sellam; Rémy Bruckert; Muriel Paul; Valérie Farrenq; Pascal Claudepierre
Journal:  Arthritis Res Ther       Date:  2012-03-09       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.